Men far less likely to prevent, screen for osteoporosis

May 15, 2015

Great Neck, NY - While the consequences of osteoporosis are worse in men than women - including death - older males are far less likely to take preventive measures against the potentially devastating bone-thinning disease or accept recommendations for screening, according to startling new research by North Shore-LIJ Health System geriatricians.

Geriatric fellow Irina Dashkova, MD, designed and led a cross-sectional survey of 146 older adults in New York and Florida that showed stunning gender differences in perspectives, beliefs and behaviors surrounding osteoporosis, which primarily affects women but also affects up to 2 million American men. Another 8 million to 13 million men in the United States have low bone mineral density, a condition known as osteopenia that's a precursor to osteoporosis.

"We were surprised at how big a difference we found between men and women regarding osteoporosis," said Dr. Dashkova, lead author of the study, which is scheduled for presentation at The American Geriatrics Society's 2015 Annual Scientific Meeting, which will take place in Washington, DC, from May 15-17.

"The fact that longevity is increasing in our population is wonderful. But we know from research that when men suffer fractures, their mortality is higher than in women and that severe medical consequences and loss of independence are much more prevalent in men," she added. "In our environment, you just get this perception that osteoporosis is a women's problem. This has to be changed, and the sooner the better."

More than 10 million Americans suffer from osteoporosis - raising their risk for serious bone fractures - and another 43 million have low bone mineral density, according to the National Osteoporosis Foundation. Prior research showed that 13% of white men in the United States over age 50 will experience at least one osteoporosis-related fracture during their lifetime.

Strikingly, the risk of death after sustaining a hip fracture is twice as high in men compared to women, and loss of independence is also more common in males. Some medical conditions and drugs that can affect osteoporosis risk are male-specific, such as prostate cancer drugs that affect the production of testosterone or the way it works in the body.

Dr. Dashkova's research, in which she collaborated with mentoring author Gisele Wolf-Klein, MD, director of geriatric education for the North Shore-LIJ Health System, examined the psychological and social factors surrounding osteoporosis influencing each gender.

Among the 146 survey respondents, roughly one-third were men with an average age of 72. More than 70% were white. Women were far more likely to have never smoked compared to men (78.8% compared to 21.3%) and markedly more likely to report a family history of osteoporosis (nearly 91% compared to 9.1%).

Additionally, while most women would accept osteoporosis screening if offered, less than 25% of men would, the survey found. Women were also more than 4 times as likely as men to take preventive measures against osteoporosis, such as taking calcium and vitamin D supplements to strengthen bones.

Dr. Wolf-Klein, also program director for the geriatric fellowship at North Shore-LIJ, noted that osteoporosis testing involves a painless, quick procedure known as a DXA scan that shouldn't be considered fearsome. But healthcare providers also aren't encouraging men to undergo screening as often as they should, she said.

"Our survey clearly establishes that physicians are just not thinking of screening men. It's only when older men fall and break their hip that someone thinks maybe we should do something to prevent them breaking the other hip," Dr. Wolf-Klein said. "Not only is society in general unaware of the problem of osteoporosis in men, men are not seeking screening and diagnosis."

Drs. Dashkova and Wolf-Klein hope their new study prods greater awareness among the public as well as clinicians, including specialists in areas such as cardiology, nephrology and endocrinology who are caring for more older adults as the population ages.

"We geriatricians are delighted to see that longevity is increasing in both males and females," Dr. Wolf-Klein said. "The average age in my practice is in the 90s, and our patients are to be congratulated because clearly they're doing something right. But we have a duty to make sure those later years are as happy and productive as can be and not spent in a wheelchair."
-end-
For media interviews during the AGS meeting, please contact Gisele Wolf-Klein, MD at 516-526-1722, gwklein11@aol.com, or Irina Dashova, MD at 516-317-9613, idashkova@nshs.edu

Northwell Health

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.